InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Hale David F, 董事. Officer active across 3 companies, notably Dermata Therapeutics, Inc.. Cumulatively, 8 disclosures have been recorded. Split: 1 buy · 2 sells. Total volume traded: €22k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 23 February 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Hale David F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
78,741 股Common StockSEC:0001654954-25-000690:0
714 股@ US$9.0416.9% 占其流量Common StockSEC:0001209191-24-004016:0
标准退出：2024年5月23日 (T+90)
30,155 股0Common StockSEC:0001654954-22-013528:0
26,441 股0Common StockSEC:0001654954-22-009455:0
15,466 股0Common StockSEC:0000905718-22-000562:0
363 股@ US$4.0602100.0% 占其流量Common StockSEC:0001209191-21-069092:0
44,777 股Common StockSEC:0000905718-21-001110:0
3,669 股@ US$4.7571.1% 占其流量Common StockSEC:0001209191-21-045049:0
8 条申报中的 8 条
About Hale David F
HALE DAVID F is a Director at Oncternal Therapeutics, Inc., Dermata Therapeutics, Inc., and BIOCEPT INC. In these roles, he participates in corporate governance and strategic decision-making. His expertise in the biopharmaceutical sector allows him to make significant contributions to board discussions, ensuring innovation and performance for the companies.
